Use of botulinum toxin type a in the management of patients with neurological disorders: A national survey

Nicola Smania, Carlo Colosimo, Anna Rita Bentivoglio, Giorgio Sandrini, Alessandro Picelli

Research output: Contribution to journalArticle

Abstract

The aim of this survey was to provide an overview of important issues relating to therapeutic strategies based on botulinum toxin type A injection for the treatment of patients with neurological disorders. Two hundred and ten physicians from neurology and neurorehabilitation units in Italian hospitals answered a questionnaire exploring some clinical aspects of the use of botulinum toxin type A in patients with spasticity/dystonia. 66% of the physicians treated patients with dystonia, 80% treated adults with spasticity, and 35% treated children with cerebral palsy. Palpation with no instrumental guidance was the injection technique most commonly used for treating patients with dystonia, spasticity and cerebral palsy; 57% of the physicians evaluated patients instrumentally before toxin injection, while 45% assessed postinjection improvements by instrumental means; 78% of the physicians prescribed (when appropriate) rehabilitation procedures after toxin injection. Our results seem to show that the routine use of botulinum toxin in clinics is far from standardized.

Original languageEnglish
Pages (from-to)253-258
Number of pages6
JournalFunctional Neurology
Volume28
Issue number4
Publication statusPublished - 2014

Keywords

  • Botulinum toxin
  • Cerebral palsy
  • Dystonia
  • Injection
  • Spasticity
  • Survey

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)

Fingerprint Dive into the research topics of 'Use of botulinum toxin type a in the management of patients with neurological disorders: A national survey'. Together they form a unique fingerprint.

  • Cite this

    Smania, N., Colosimo, C., Rita Bentivoglio, A., Sandrini, G., & Picelli, A. (2014). Use of botulinum toxin type a in the management of patients with neurological disorders: A national survey. Functional Neurology, 28(4), 253-258.